Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the reinforcing effects of the cannabinoid CB 1 receptor antagonist, SR141716, in rhesus monkeys

By Beardsley P.M.   Dance M.E.   Balster R.L.   Munzar P.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ antagonist SR 141716A in rhesus monkeys pretreated with ∆⁹-tetrahydrocannabinol

By McMahon Lance  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 306-314

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

By Rowland Neil   Mukherjee Monica   Robertson Kimberly  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite